Helen Milton

No más puestos en curso

Health Technology

Consumer Services

Perfil

Helen Milton formerly worked at Keryx Biopharmaceuticals, Inc., as Vice President-Global Regulatory Affairs & Quality from 2014 to 2017, AMAG Pharmaceuticals, Inc., as Senior VP-Regulatory Affairs & Quality in 2020, Mallinckrodt Pharmaceuticals, as Senior VP-Regulatory Affairs & Pharmacovigilance from 2021 to 2022, and Viridian Therapeutics, Inc., as Senior Vice President-Regulatory Affairs from 2023 to 2024.
Dr. Milton received her undergraduate degree and doctorate degree from The University of Liverpool.

Antiguos cargos conocidos de Helen Milton.

Empresas	Cargo	Fin
VIRIDIAN THERAPEUTICS, INC.	Consejero General	02/01/2024
AMAG PHARMACEUTICALS, INC.	Consejero General	01/12/2020
KERYX BIOPHARMACEUTICALS	Consejero General	01/05/2017

Ver el detalle de la experiencia de Helen Milton.

Formación de Helen Milton.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Helen Milton.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Keryx Biopharmaceuticals, Inc. Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease	Health Technology
The University of Liverpool The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Viridian Therapeutics, Inc. Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products	Health Technology